(S)-tert-Butyl3-(2-hydroxyethyl)piperazine-1-carboxylate CAS:1273577-11-9

(S) -tert-Butyl 3-(2-hydroxyethyl)piperazine-1-carboxylate holds promise in medicinal chemistry as a versatile intermediate for developing potential drug candidates targeting specific molecular targets or disease pathways. Researchers can explore its pharmacological properties by evaluating its enantiomeric purity and studying its interactions with biological systems to assess its therapeutic potential. The compound's chiral nature may be leveraged to design selective pharmaceutical agents with enhanced efficacy and reduced adverse effects. In organic synthesis, this compound serves as a key precursor for accessing structurally diverse molecules through functional group transformations or derivatization reactions. Its incorporation into synthetic pathways allows for the construction of complex molecular architectures for studying structure-activity relationships, designing new materials, or exploring asymmetric catalysis. By utilizing its stereochemistry and reactivity, researchers can advance synthetic methodologies and create innovative compounds for scientific and industrial applications. Overall, (S)-tert-Butyl 3-(2-hydroxyethyl)piperazine-1-carboxylate showcases versatility and potential in drug discovery, organic synthesis, and chemical innovation, underscoring its significance in advancing scientific knowledge and pharmaceutical advancements.